Double digit earnings growth for pharma in next 2 yrs; 4 stocks to bet on: Sriraam Rathi
The pharma sector is set to experience double-digit earnings growth over the next couple of years, supporting valuations, according to Sriraam Rathi of BNP Paribas Securities. Despite historically underperforming compared to Nifty 50, Nifty Pharma’s outlook is positive, and there is scope for re-rating the sector, with select stocks offering significant opportunities, said Rathi.
